The recent federal reforms to pharmacy benefit managers are a meaningful step in the right direction, but the work is not ...

Pharmacy benefit managers have become popular punching bags, primarily because of spread pricing and steering patients to affiliated pharmacies.

Eli Lilly and Company just secured a big win as it looks to expand GLP-1 access, mending its partnership with top pharmacy ...

Explore US health insurance stocks, key managed care risks, Medicare Advantage pressure, and major healthcare names shaping ...

While PBM reforms that passed earlier this year will spur further changes in the way business is conducted, it’s anti-trust ...

Inclusion of weight loss drugs on insurer formularies is a meaningful step towards expanding access. But having a product ...

In a reversal from last year, CVS will begin covering Eli Lilly's Zepbound and Foundayo in its standard prescription plan, a win for GLP-1 patients.

PrimeRx reports that independent pharmacies struggle to compete with big retailers like CVS and Walgreens due to pricing ...

CVS Health will reinstate coverage of Eli Lilly's weight-loss injectable Zepbound and begin coverage of the anti-obesity pill ...

The top pharmacy benefit manager (PBM) in the U.S., CVS Caremark, will restore coverage to obesity products from Eli Lilly, ...

The law, which would prohibit PBM conglomerates from owning or operating pharmacies, illegally boots out-of-state companies ...